Primary immunodeficiency Disease (PIDD)
Showing 1 - 25 of >10,000
COVID-19 Vaccine Responses in PIDD Subjects
Recruiting
- X-linked Agammaglobulinemia
- +6 more
-
Saint Petersburg, Florida
- +2 more
Apr 7, 2022
Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- TAK-881
- HYQVIA
- (no location specified)
Feb 23, 2023
Primary Immunodeficiency Diseases (PID) Trial (TAK-881)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- TAK-881
- (no location specified)
Oct 4, 2023
Primary Immune Deficiency Trial (Asceniv™)
Recruiting
- Primary Immune Deficiency
- Asceniv™
-
Centennial, Colorado
- +2 more
Sep 13, 2022
Primary Immunodeficiency Diseases (PID) Trial in United States (HYQVIA, GAMMAGARD LIQUID)
Completed
- Primary Immunodeficiency Diseases (PID)
- HYQVIA
- GAMMAGARD LIQUID
-
Birmingham, Alabama
- +18 more
Sep 28, 2022
Tool for Primary Immunodeficiency Disease (PID) in Pakistan
Not yet recruiting
- Primary Immunodeficiency Diseases
- Primary Immunodeficiency (PID) Rapid Diagnostic Test (RDT)
-
Karachi, PakistanAga Khan University Hospital
Feb 24, 2023
Primary Immunodeficiency Disease Trial (IVIG)
Not yet recruiting
- Primary Immunodeficiency Disease
- IVIG
- (no location specified)
Oct 16, 2023
Primary Immunodeficiency Disease Trial in Japan (IGSC 20% infusion)
Active, not recruiting
- Primary Immunodeficiency Disease
- IGSC 20% infusion
-
Nagoya, Aichi, Japan
- +7 more
Jan 4, 2023
5% Treatment Naïve Intravenous Immunoglobulin Primary
Completed
- Primary Immunodeficiency Disease (PIDD)
-
Newport Beach, California
- +3 more
Aug 6, 2019
Primary Immunodeficiency Diseases (PID) Trial (TAK-771)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- (no location specified)
Aug 22, 2022
Fibroblast-Derived Cell Lines From Skin Biopsies of
Enrolling by invitation
- Primary Immunodeficiency
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Participation in a Research Registry for Immune Disorders
Recruiting
- Primary Immunodeficiencies
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Primary Immunodeficiency Disease Trial (Boya IVIG)
Not yet recruiting
- Primary Immunodeficiency Disease
- Boya IVIG
- (no location specified)
Nov 21, 2023
Primary Immunodeficiency Diseases (PID) Trial in Canada, United States (Immune Globulin Intravenous (Human), 10% Solution,
Completed
- Primary Immunodeficiency Diseases (PID)
- Immune Globulin Intravenous (Human), 10% Solution
- Immune Globulin Subcutaneous (Human), 20% Solution
-
Irvine, California
- +17 more
Jun 30, 2021
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Busulfan test dose
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Primary Immune Deficiency Disorder Trial in United States (Bivigam, Other)
Active, not recruiting
- Primary Immune Deficiency Disorder
- Bivigam
- Other
-
Carpinteria, California
- +16 more
Jan 30, 2023
Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,
Recruiting
- Primary T-cell Immunodeficiency Disorders
- +4 more
- Immunosuppression Only Conditioning -Closed with amendment L
- +4 more
-
Bethesda, Maryland
- +1 more
Jul 26, 2022
Primary Immune Deficiency Disorders (PIDD) Trial in United States (Nabi-IGIV 10% [Immune Globulin Intravenous (Human). 10%])
Completed
- Primary Immune Deficiency Disorders (PIDD)
- Nabi-IGIV 10% [Immune Globulin Intravenous (Human). 10%]
-
Birmingham, Alabama
- +16 more
Jul 28, 2021
Primary Immunodeficiency Diseases (PID) Trial in United States (Immune Globulin Infusion (Human), 10%, Recombinant human
Completed
- Primary Immunodeficiency Diseases (PID)
- Immune Globulin Infusion (Human), 10%
- Recombinant human hyaluronidase
-
Irvine, California
- +9 more
Apr 30, 2021
Intestinal Inflammation in People With Primary Immune
Recruiting
- Chronic Granulomatous Disease
- Inflammatory Bowel Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Primary Immunodeficiency Disease Trial in United States (Kedrion IVIG 10%)
Completed
- Primary Immunodeficiency Disease
- Kedrion IVIG 10%
-
North Palm Beach, Florida
- +10 more
Jan 26, 2022
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Immunosuppression Only Conditioning
- +3 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Suppurative Lung Disease in Children and Adults
Recruiting
- Primary Ciliary Dyskinesia
- +2 more
- Genetic Testing for PCD or PID
- Unaffected Family Member Genetic Testing
-
Palo Alto, California
- +7 more
Mar 30, 2022
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Primary Immune Deficiency Disorders, Metabolic Disease Trial in Saint Petersburg (Haploidentical Hematopoietic Cell
Recruiting
- Primary Immune Deficiency Disorders
- Metabolic Disease
- Haploidentical Hematopoietic Cell Transplantation
-
Saint Petersburg, FloridaJohns Hopkins All Children's Hospital
Sep 9, 2021